Search Results

There are 5566 results for: content related to: Spironolactone is More Effective Than Eplerenone at Lowering Blood Pressure in Patients With Primary Aldosteronism

  1. Pharmacokinetics of Eplerenone After Single and Multiple Dosing in Subjects With and Without Renal Impairment

    The Journal of Clinical Pharmacology

    Volume 45, Issue 7, July 2005, Pages: 810–821, Dr William R. Ravis, Ms Susan Reid, Dr Domenic A. Sica and Dr Dwain S. Tolbert

    Article first published online : 25 MAR 2013, DOI: 10.1177/0091270005275894

  2. Can Renin Status Predict the Antihypertensive Efficacy of Eplerenone Add-On Therapy?

    The Journal of Clinical Pharmacology

    Volume 43, Issue 11, November 2003, Pages: 1203–1210, Dr. L. Michael Prisant, Dr Henry Krum, Dr. Barbara Roniker, Dr. Scott L. Krause, Dr. Kaffa Fakouhi and Dr. Weizhong He

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270003258189

  3. Targeting the aldosterone pathway in cardiovascular disease

    Fundamental & Clinical Pharmacology

    Volume 26, Issue 1, February 2012, Pages: 135–145, Finn Gustafsson, Michel Azizi, Johann Bauersachs, Frederic Jaisser and Patrick Rossignol

    Article first published online : 2 NOV 2011, DOI: 10.1111/j.1472-8206.2011.01004.x

  4. Aldosterone antagonists for preventing the progression of chronic kidney disease

    Intervention Review

    The Cochrane Library

    Davide Bolignano, Suetonia C Palmer, Sankar D Navaneethan and Giovanni FM Strippoli

    Published Online : 29 APR 2014, DOI: 10.1002/14651858.CD007004.pub3

  5. Selection of a mineralocorticoid receptor antagonist for patients with hypertension or heart failure

    European Journal of Heart Failure

    Volume 16, Issue 2, February 2014, Pages: 143–150, Javaid Iqbal, Yasir Parviz, Bertram Pitt, John Newell-Price, Abdallah Al-Mohammad and Faiez Zannad

    Article first published online : 14 DEC 2013, DOI: 10.1111/ejhf.31

  6. You have full text access to this OnlineOpen article
    Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial

    European Journal of Heart Failure

    Volume 11, Issue 11, November 2009, Pages: 1099–1105, Chris Adamopoulos, Ali Ahmed, Renaud Fay, Michael Angioi, Gerasimos Filippatos, John Vincent, Bertram Pitt, Faiez Zannad and the EPHESUS Investigators

    Article first published online : 29 OCT 2009, DOI: 10.1093/eurjhf/hfp136

  7. Eplerenone-Mediated Regression of Electrical Activation Delays and Myocardial Fibrosis in Heart Failure

    Journal of Cardiovascular Electrophysiology

    Volume 25, Issue 5, May 2014, Pages: 537–544, CHRISTINE TANAKA-ESPOSITO, SUBHA VARAHAN, DARWIN JEYARAJ, YUAN LU and BRUCE S. STAMBLER

    Article first published online : 10 MAR 2014, DOI: 10.1111/jce.12379

  8. You have full text access to this OnlineOpen article
    Aldosterone affects blood flow and vascular tone regulated by endothelium-derived NO: therapeutic implications

    British Journal of Pharmacology

    Volume 168, Issue 3, February 2013, Pages: 519–533, Noboru Toda, Sadanobu Nakanishi and Shinichi Tanabe

    Article first published online : 16 JAN 2013, DOI: 10.1111/j.1476-5381.2012.02194.x

  9. Renoprotective effects of mineralocorticoid receptor blockade in heminephrectomized (pro)renin receptor transgenic rats

    Clinical and Experimental Pharmacology and Physiology

    Volume 37, Issue 5-6, May/June 2010, Pages: 569–573, Yuki Mizuguchi, Atsuhiro Ichihara, Yasufumi Seki, Mariyo Sakoda, Asako Kurauchi-Mito, Tatsuya Narita, Kenichiro Kinouchi, Kanako Bokuda and Hiroshi Itoh

    Article first published online : 17 JAN 2010, DOI: 10.1111/j.1440-1681.2010.05360.x

  10. Selective Aldosterone Blockade Suppresses Atrial Tachyarrhythmias in Heart Failure

    Journal of Cardiovascular Electrophysiology

    Volume 17, Issue 5, May 2006, Pages: 534–541, SUNIL C. SHROFF, KYUNGMOO RYU, NICHOLE L. MARTOVITZ, BRIAN D. HOIT and BRUCE S. STAMBLER

    Article first published online : 14 FEB 2006, DOI: 10.1111/j.1540-8167.2006.00372.x

  11. You have free access to this content
    Treatment Considerations With Aldosterone Receptor Antagonists

    The Journal of Clinical Hypertension

    Volume 13, Issue 1, January 2011, Pages: 65–69, Domenic A. Sica and John M. Flack

    Article first published online : 4 OCT 2010, DOI: 10.1111/j.1751-7176.2010.00377.x

  12. You have free access to this content
    The Use of Aldosterone Receptor Blockers in the Treatment of Hypertension

    The Journal of Clinical Hypertension

    Volume 6, Issue 11, November 2004, Pages: 632–635, Myron H. Weinberger

    Article first published online : 25 MAY 2007, DOI: 10.1111/j.1524-6175.2004.03057.x

  13. EPLERENONE PREVENTS ADVERSE CARDIAC REMODELLING INDUCED BY PRESSURE OVERLOAD IN ATRIAL NATRIURETIC PEPTIDE-NULL MICE

    Clinical and Experimental Pharmacology and Physiology

    Volume 33, Issue 9, September 2006, Pages: 773–779, Veronica Franco, Yiu-Fai Chen, Ji A Feng, Peng Li, Dajun Wang, Erum Hasan, Suzanne Oparil and Gilbert J Perry

    Article first published online : 10 AUG 2006, DOI: 10.1111/j.1440-1681.2006.04434.x

  14. You have full text access to this OnlineOpen article
    Eplerenone: A Selective Aldosterone Blocker

    Cardiovascular Drug Reviews

    Volume 21, Issue 3, September 2003, Pages: 169–184, Charles T. Stier Jr.

    Article first published online : 7 JUN 2006, DOI: 10.1111/j.1527-3466.2003.tb00114.x

  15. Differences in the determinants of eplerenone, spironolactone and aldosterone binding to the mineralocorticoid receptor

    Clinical and Experimental Pharmacology and Physiology

    Volume 31, Issue 10, October 2004, Pages: 704–709, Fraser M Rogerson, Yizhou Yao, Brian J Smith and Peter J Fuller

    Article first published online : 19 NOV 2004, DOI: 10.1111/j.1440-1681.2004.04079.x

  16. You have full text access to this OnlineOpen article
    Anti-inflammatory effects of eplerenone on viral myocarditis

    European Journal of Heart Failure

    Volume 11, Issue 4, April 2009, Pages: 349–353, Jie Xiao, Miho Shimada, Wenling Liu, Dayi Hu and Akira Matsumori

    Article first published online : 29 MAR 2009, DOI: 10.1093/eurjhf/hfp023

  17. Eplerenone improves prognosis in postmyocardial infarction diabetic patients with heart failure: results from EPHESUS

    Diabetes, Obesity and Metabolism

    Volume 10, Issue 6, June 2008, Pages: 492–497, J. H. O’Keefe, H. Abuissa and B. Pitt

    Article first published online : 8 MAY 2007, DOI: 10.1111/j.1463-1326.2007.00730.x

  18. You have free access to this content
    Mineralocorticoid receptor activation in myocardial infarction and failure: recent advances

    European Journal of Clinical Investigation

    Volume 42, Issue 10, October 2012, Pages: 1112–1120, Paolo Galuppo and Johann Bauersachs

    Article first published online : 26 APR 2012, DOI: 10.1111/j.1365-2362.2012.02676.x

  19. You have free access to this content
    Efficacy and Safety of the Selective Aldosterone Blocker Eplerenone in Japanese Patients With Hypertension: A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study

    The Journal of Clinical Hypertension

    Volume 6, Issue 4, April 2004, Pages: 175–185, Takao Saruta, 1 Shigeru Kageyama, 2 Toshio Ogihara, 3 Kunio Hiwada, 4 Masayo Ogawa, 5 Kazuji Tawara, 6 Marjorie Gatlin, 7 Susan Garthwaite, 7 Richard Bittman and 8 Jeffrey Patrick 7

    Article first published online : 25 MAY 2007, DOI: 10.1111/j.1524-6175.2004.03146.x

  20. You have full text access to this OnlineOpen article
    Evaluation of eplerenone in the subgroup of EPHESUS patients with baseline left ventricular ejection fraction ≤30%

    European Journal of Heart Failure

    Volume 8, Issue 3, May 2006, Pages: 295–301, Bertram Pitt, Mihai Gheorghiade, Faiez Zannad, Jeffrey L. Anderson, Dirk J. van Veldhuisen, Alexander Parkhomenko, Ramon Corbalan, Eric Q. Klug, Robin Mukherjee, Henry Solomon and On behalf of the EPHESUS Investigators

    Article first published online : 13 MAY 2006, DOI: 10.1016/j.ejheart.2005.11.008